FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| JCB Laboratories LLC | 177167470 | 71266-8110 | 71266-8110-1 | Epinephrine | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-6276 | 71266-6276-3 | Epinephrine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | .5 mg/1 mL; 40 mg/1 mL; 5 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-6477 | 71266-6477-5 | Iohexol | 240 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-6478 | 71266-6478-3 | Iohexol | 300 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-8230 | 71266-8230-5 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 5 mg/1 mL; 25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-8231 | 71266-8231-5 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 5 mg/1 mL; 100 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-8231 | 71266-8231-1 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 5 mg/1 mL; 100 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-8230 | 71266-8230-1 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 5 mg/1 mL; 25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| LEESAR INC | 025104311 | 68985-012 | 68985-012-93 | Oxytocin | 30 U/500 mL | 2019-2 | valid | 2026-11-14 | |
| LEESAR INC | 025104311 | 68985-004 | 68985-004-94 | Phenylephrine Hydrochloride | 40 mg/250 mL | 2019-2 | valid | 2026-11-14 | |
| LEESAR INC | 025104311 | 68985-629 | 68985-629-91 | Succinylcholine Chloride | 20 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| LEESAR INC | 025104311 | 68985-304 | 68985-304-92 | Vancomycin Hydrochloride | 5 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| LEESAR INC | 025104311 | 68985-324 | 68985-324-93 | Vancomycin Hydrochloride | 6 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| LEESAR INC | 025104311 | 68985-311 | 68985-311-91 | Calcium Gluconate | 20 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| LEESAR INC | 025104311 | 68985-615 | 68985-615-91 | Diltiazem Hydrochloride | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| LEESAR INC | 025104311 | 68985-198 | 68985-198-91 | "ropivacaine Hydrochloride, (r)-" | 5 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| LEESAR INC | 025104311 | 68985-540 | 68985-540-95 | Heparin Sodium | 10 U/1 mL | 2019-2 | valid | 2026-11-14 | |
| LEESAR INC | 025104311 | 68985-540 | 68985-540-91 | Heparin Sodium | 10 U/1 mL | 2019-2 | valid | 2026-11-14 | |
| LEESAR INC | 025104311 | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| LEESAR INC | 025104311 | 68985-153 | 68985-153-85 | Amiodarone Hydrochloride | 1.8 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-001 | 70360-001-60 | Bevacizumab | 25 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-001 | 70360-001-02 | Bevacizumab | 25 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-007 | 70360-007-35 | Cefuroxime Sodium | 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Leiter's Compounding | 079215020 | 70360-058 | 70360-058-39 | Edetate Disodium | 30 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | Midazolam | 1 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Medi-Fare Drug | 091326520 | 61141-1337 | 61141-1337-1 | Midazolam | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | Neostigmine Methylsulfate | 1 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Medi-Fare Drug | 091326520 | 61141-4834 | 61141-4834-1 | Nitroglycerin | 100 ug/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-4813 | 61141-4813-1 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-4538 | 61141-4538-4 | Povidone-Iodine | 50 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-4795 | 61141-4795-2 | Betamethasone Sodium Phosphate; Betamethasone Acetate | 3 mg/1 mL; 3 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-4536 | 61141-4536-4 | Proparacaine Hydrochloride | 5 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-1370 | 61141-1370-5 | Ropivacaine Hydrochloride | 5 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-1351 | 61141-1351-1 | Succinylcholine Chloride | 20 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 1.25 mg/1 mL; 2 ug/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-4535 | 61141-4535-3 | Cefuroxime Sodium | 1 mg/.1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-1374 | 61141-1374-5 | Ephedrine Sulfate | 5 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-1350 | 61141-1350-5 | Ephedrine Sulfate | 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | Esmolol Hydrochloride | 10 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Medi-Fare Drug | 091326520 | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 10 ug/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-4836 | 61141-4836-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2 ug/1 mL; 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-1373 | 61141-1373-5 | Glycopyrrolate | .2 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| Medi-Fare Drug | 091326520 | 61141-1326 | 61141-1326-1 | Iopamidol | 408 mg/1 mL | 2019-2 | valid | 2026-11-14 | |
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Neostigmine Methylsulfate | 3 mg/3 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Neostigmine Methylsulfate | 5 mg/5 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Oxytocin | 20 [iU]/1010 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Oxytocin | 30 [iU]/510 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Oxytocin | 30 [iU]/510 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Oxytocin | 20 [iU]/1010 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Atropine Sulfate | .8 mg/2 mL | 2019-2 | source_no_ndc | 2026-11-14 |